Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario A Ostrowski

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
The Journal of Clinical Investigation|December 5, 2018
Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activationCatia T Perciani, Bashir Farah, Rupert Kaul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Preferential apoptosis of HIV-1-specific CD4+ T cellsFeng Yun Yue, Colin M Kovacs, Rowena C Dimayuga, et al.
Journal of Negative Results in Biomedicine|January 12, 2013
Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methodsR Brad Jones, Fabio E Leal, Aaron M Hasenkrug, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2013
T cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatasesKiera L Clayton, Matthew S Haaland, Matthew B Douglas-Vail, et al.
Vaccine|June 20, 2008
CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individualsJun Liu, Qigui Yu, Geoffrey W Stone, et al.
Journal of Virology|June 9, 2017
Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 ReservoirShariq Mujib, Jun Liu, A K M Nur-Ur Rahman, et al.
Journal of Virology|July 13, 2018
Characterization of the Plasmacytoid Dendritic Cell Response to Transmitted/Founder and Nontransmitted Variants of HIV-1Jordan Ari Schwartz, Hongliang Zhang, Zachary Ende, et al.
Immunologic Research|September 28, 2006
Why can't the immune system control HIV-1? Defining HIV-1-specific CD4+ T cell immunity in order to develop strategies to enhance viral immunityMario A Ostrowski, Qigui Yu, Feng Yun Yue, et al.
Cellular Microbiology|August 26, 2010
Neisseria gonorrhoeae effectively blocks HIV-1 replication by eliciting a potent TLR9-dependent interferon-α response from plasmacytoid dendritic cellsWendy N Dobson-Belaire, Anuradha Rebbapragada, Rebecca J Malott, et al.
The Journal of Infectious Diseases|May 26, 2018
Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)-Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive WomenCatia T Perciani, Manmeet Sekhon, Sabrina Hundal, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Investigation|December 5, 2018
Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activationCatia T Perciani, Bashir Farah, Rupert Kaul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Preferential apoptosis of HIV-1-specific CD4+ T cellsFeng Yun Yue, Colin M Kovacs, Rowena C Dimayuga, et al.
Journal of Negative Results in Biomedicine|January 12, 2013
Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methodsR Brad Jones, Fabio E Leal, Aaron M Hasenkrug, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2013
T cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatasesKiera L Clayton, Matthew S Haaland, Matthew B Douglas-Vail, et al.
Vaccine|June 20, 2008
CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individualsJun Liu, Qigui Yu, Geoffrey W Stone, et al.
Journal of Virology|June 9, 2017
Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 ReservoirShariq Mujib, Jun Liu, A K M Nur-Ur Rahman, et al.
Journal of Virology|July 13, 2018
Characterization of the Plasmacytoid Dendritic Cell Response to Transmitted/Founder and Nontransmitted Variants of HIV-1Jordan Ari Schwartz, Hongliang Zhang, Zachary Ende, et al.
Immunologic Research|September 28, 2006
Why can't the immune system control HIV-1? Defining HIV-1-specific CD4+ T cell immunity in order to develop strategies to enhance viral immunityMario A Ostrowski, Qigui Yu, Feng Yun Yue, et al.
Cellular Microbiology|August 26, 2010
Neisseria gonorrhoeae effectively blocks HIV-1 replication by eliciting a potent TLR9-dependent interferon-α response from plasmacytoid dendritic cellsWendy N Dobson-Belaire, Anuradha Rebbapragada, Rebecca J Malott, et al.
The Journal of Infectious Diseases|May 26, 2018
Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)-Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive WomenCatia T Perciani, Manmeet Sekhon, Sabrina Hundal, et al.
Pageof 8